Day: January 30, 2024

Better than expected grades and widths from deep level drilling anticipated to support increased overall resource at BlanketFigure 1Eroica Orebody – Drilling from 750 metres below surfaceFigure 2Blanket Orebodies – Drilling from 930 metres below surfaceFigure 3Blanket Orebodies – Drilling from 870 metres below surfaceFigure 4AR South – Drilling from 1,110 metres below surfaceST HELIER, Jersey, Jan. 30, 2024 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or the “Company”) (NYSE AMERICAN, AIM and VFEX: CMCL) is pleased to report further encouraging results from the deep level drilling programme at Blanket Mine which is currently evaluating the continuity of the mineralised zones on the Blanket and Eroica ore bodies in anticipation of delineating an increased...

Since 2022 and first to market, Sportradar has been transforming the status quo for trading betting markets Achieves PwC ISAE 3402 Type1 certification, validating the accuracy of its financial reconciliation processes ST. GALLEN, Switzerland, Jan. 30, 2024 (GLOBE NEWSWIRE) — Sportradar’s (NASDAQ: SRAD) Alpha Odds, its automated odds recalculation tool which allows operators to generate bespoke betting prices in line with their risk exposure and liabilities, delivered an average profit increase of 10% for clients in 2023, compared to the performance of its conventional odds product. Launched in 2022, Alpha Odds boasts a client roster of more than 60 betting operators around the world. Leveraging Sportradar’s advanced artificial intelligence capabilities, the pricing models within Alpha Odds more accurately predict the probability...

                                        Agfa and EFI Forge Strategic Partnership to Propel Digital Print Transformation Mortsel, Belgium – Londonderry, NH, USA – January 30, 2024 – 7:45 a.m. CET Agfa and EFI proudly announce that they have entered into a global strategic partnership aimed at leveraging each other’s cutting-edge technologies. The collaboration between two industry leaders marks a significant milestone in the wide-format inkjet printing arena. Within the framework of the partnership, Agfa will integrate EFI’s roll-to-roll system into its offerings, while EFI will incorporate Agfa’s high-end hybrid inkjet printers into its suite of solutions. Both printing platforms have established themselves as frontrunners in their respective fields. Customers and prospects stand to gain unparalleled advantages from this strategic...

Bilbao, Spain, January 30, 2024.- Virtualware (EPA: MLVIR), the European leader in virtual reality has signed a partnership agreement with GE21 Realidade Virtual to boost VIROO’s presence in Brazil. The Brazilian VR company, which is part of the GE21 group, has officially joined the VIROO partner program. This represents a strategic partnership focused on expanding the reach of the Enterprise VR platform VIROO especially in mining, geosciences, and engineering industries.  This collaboration began last October at the largest annual nursing event in Latin America, CBCENF celebrated in João Pessoa, Brazil where both companies were showcasing VIROO,  presenting the benefits of using VR in medical training. “We are eliminating the complexities and barriers often associated with VR technology, thanks to VIROO. At GE21 Realidade Virtual,...

Hyloris and Purna Female Healthcare Announce Positive Results from Phase 2 Trial in Patients with Acute Vulvovaginal Candidiasis (VVC)Both treatment arms with the combination of Miconazole (2%) and Domiphen Bromide (0.14% or 0.29%) demonstrated excellent safety and tolerability Low dose (0.14%) showed significant improvement over active control in clinical and mycological outcome at day 291Liège, Belgium – 30 January 2024, 07:00 AM CET – Regulated information – Inside information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, today announces positive results for the phase 2 trial of Miconazole Domiphen-Bromide (MCZ-DB) in patients with acute vulvovaginal candidiasis. The phase 2 trial of MCZ-DB was a 12-week,...

In Q1 2023/24, Ambu delivered 14% organic revenue growth and a 10.0% EBIT margin before special items. This was driven by Endoscopy Solutions growing 25%, due to continued high double-digit growth within urology and ENT, combined with pulmonology growing 18%. “I am pleased with the performance within the first quarter of the year, showcasing our continued commitment to delivering strong profitable growth. With 25% growth in Endoscopy Solutions, an increased profitability level and a positive free cash flow of DKK 135m, we are off to a solid start to meet our financial guidance for this fiscal year. Whereas the first year of our transformative ZOOM IN strategy revolved around re-building our financial foundation, this second year is dedicated to accelerated growth at higher margins. I am excited to continue our trajectory along with my...

Regulated Information – Inside Information 30 January 2024, 7:00 a.m. CET, Antwerp, Belgium: VGP NV (‘VGP’ or ‘the Group’) announces the acquisition of 21 hectares, currently used as a car park, located on part of the Stellantis site in Mulhouse, France. Two years after its arrival on the French market, VGP now has a secure 73-hectare portfolio of land on which to develop almost 350,000 m² of industrial, logistics and business premises. At the end of 2024, VGP will complete the first delivery of 40,000 m² on the Petit-Couronne site in Rouen. In a dynamic region that is currently experiencing a shortage of industrial and logistics space, this new park will help to meet the growing needs of businesses. Located in the commune of Sausheim, near Mulhouse, the site benefits from an exceptional location and accessibility, at the junction...

               Gdańsk, Poland – 30 January 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG) , a clinical-stage biotechnology company developing cell therapies for a wide range of autoimmune diseases, announced that Prof. Piotr Trzonkowski, CEO, has co-authored a peer-reviewed article in Frontiers in Immunology, the world’s fifth most-cited immunology journal, laying out the decades of scientific progress underlying the company’s portfolio of ground-breaking clinical-stage therapies for diseases such as Type-1 Diabetes (T1D) and Multiple Sclerosis (MS). Prof. Trzonkowski, together with other researchers from the Medical University of Gdańsk, joined contributing authors from the teams of Prof. Ye Htun Oo at University of Birmingham, Prof. Anke Fuchs from the Technical University of Dresden, and Prof. Natalia Marek-Trzonkowska from the International...

With the founding of “Feintool System Parts India Pvt Ltd” and a new production site in the metropolitan region of Pune, Feintool is consolidating its strategic position as an important supplier of high-precision parts in Asian automotive production. With an initial investment of CHF 15 million, Feintool is moving closer to long-standing customers who already produce in the region. “Feintool System Parts India Pvt Ltd” is establishing its presence in a promising market and reducing its CO2 footprint through significantly lower delivery-related emissions. Feintool production in Pune is expected to start in summer 2025. «With our expansion into India, we are meeting the needs of our long-standing customers, entering a promising geographic market and contributing to shorter and, therefore, ecologically sustainable...